⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TVRD News
Tvardi Therapeutics, Inc. Common Stock
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
globenewswire.com
TVRD
Form 8-K
sec.gov
TVRD
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
globenewswire.com
TVRD
Form 8-K
sec.gov
TVRD
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
TVRD
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
TVRD
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
globenewswire.com
TVRD
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Ready to Announce with Confidence?
newsfilecorp.com
TVRD
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
globenewswire.com
TVRD
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
prnewswire.com
TVRD